AGM and Interim Management Statement

RNS Number : 0897X

Victrex PLC

05 February 2013

 



Tuesday 5 February 2013

Victrex plc

AGM and Interim Management Statement

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2012 to date:

"We are pleased to announce that, despite the continuing global economic challenges, both of our business units are showing resilience in trading so far this year.

Group sales volume for the four months to January is 2% ahead of the same period last year and Invibio revenues for the same period are broadly in line with the prior year.

Whilst early in the financial year, we remain confident of the potential for growth in both business units as the year progresses.

The Company remains in an excellent financial position with a healthy balance sheet, strong cash generation and no significant changes in its financial position since 30 September 2012." 

Victrex will provide a trading update for the six months to 31 March 2013 on Tuesday 9 April 2013.

Victrex will host a conference call at 8.30 a.m. today for analysts. If you would like more details, please contact Rosa Smith at MHPC on 0203 128 8560 / [e-mail].

Enquiries

Victrex plc Anita Frew, Chairman                         David Hummel, Chief Executive Steve Barrow, Finance Director	0203 128 8100 (5 February 2013) 01253 897700 (thereafter)
MHP Communications Nick Denton / Barnaby Fry / Ian Payne	0203 128 8100

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX^® PEEK polymer, a high performance, easy to process thermoplastic.

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio^® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

 

END

 

 

IMSMMGGZNDNGFZM